SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. K. Haugen, V. S. Ramachandran, D. Misra, T. Neogi, J. Niu, T. Yang, Y. Zhang, D. T. Felson, Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham Heart Study, Annals of the Rheumatic Diseases, 2015, 74, 1, 74

    CrossRef

  2. 2
    Yang Hu, Cui-Yun Li, Xiao-Ming Wang, Yong-Hua Yang, Hai-Liang Zhu, 1,3,4-Thiadiazole: Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry, Chemical Reviews, 2014, 114, 10, 5572

    CrossRef

  3. 3
    Joshua J. Gagne, Shirley V. Wang, Jeremy A. Rassen, Sebastian Schneeweiss, A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment, Pharmacoepidemiology and Drug Safety, 2014, 23, 6
  4. 4
    Bhulan Kumar Singh, Syed Ehtaishamul Haque, Krishna Kolappa Pillai, Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 2, 143

    CrossRef

  5. 5
    Nicholas Moore, Francesco Salvo, Mai Duong, Patrick Blin, Antoine Pariente, Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC, Expert Opinion on Drug Safety, 2014, 13, 2, 167

    CrossRef

  6. 6
    Payal Kohli, Ph. Gabriel Steg, Christopher P. Cannon, Sidney C. Smith, Kim A. Eagle, E. Magnus Ohman, Mark J. Alberts, Elaine Hoffman, Jianping Guo, Tabassome Simon, Emmanuel Sorbets, Shinya Goto, Deepak L. Bhatt, NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease, The American Journal of Medicine, 2014, 127, 1, 53

    CrossRef

  7. 7
    Beny Charchian, Bianca Tribuzio, Mauro Zappaterra, Mona Zall, Regenerative Spinal Therapies for Low Back Pain, Current Physical Medicine and Rehabilitation Reports, 2014, 2, 1, 41

    CrossRef

  8. 8
    Neal Stuart Gerstein, Wendy Hawks Gerstein, Michael Christopher Carey, Nicholas Chee Kong Lam, Harish Ram, Nicholas Ryan Spassil, Peter Mark Schulman, The Thrombotic and Arrhythmogenic Risks of Perioperative NSAIDs, Journal of Cardiothoracic and Vascular Anesthesia, 2014, 28, 2, 369

    CrossRef

  9. 9
    Chul-Hwan Moon, Ogon Kwon, Chang-Hoon Woo, Hee-Duk Ahn, Young-Sam Kwon, Soo-Jin Park, Chang-Hyun Song, Sae-Kwang Ku, Therapeutic Effect of Irradiation of Magnetic Infrared Laser on Osteoarthritis Rat Model, Photochemistry and Photobiology, 2014, 90, 5
  10. 10
    Sengwee Toh, Joann E. Manson, An Analytic Framework for Aligning Observational and Randomized Trial Data: Application to Postmenopausal Hormone Therapy and Coronary Heart Disease, Statistics in Biosciences, 2013, 5, 2, 344

    CrossRef

  11. 11
    E. J. Coulson, W.-F. Ng, I. Goff, H. E. Foster, Cardiovascular risk in juvenile idiopathic arthritis, Rheumatology, 2013, 52, 7, 1163

    CrossRef

  12. 12
    Patrick B. Ryan, Martijn J. Schuemie, Emily Welebob, Jon Duke, Sarah Valentine, Abraham G. Hartzema, Defining a Reference Set to Support Methodological Research in Drug Safety, Drug Safety, 2013, 36, S1, 33

    CrossRef

  13. 13
    Mina Tadrous, Joshua J. Gagne, Til Stürmer, Suzanne M. Cadarette, Disease risk score as a confounder summary method: systematic review and recommendations, Pharmacoepidemiology and Drug Safety, 2013, 22, 2
  14. 14
    Olivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, Farzin Beygui, Johanne Silvain, Anne Bellemain-Appaix, Guillaume Cayla, Thomas Chastre, Iris Baumgartner, Joachim Röther, Uwe Zeymer, Deepak L. Bhatt, Gabriel Steg, Gilles Montalescot, Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors, International Journal of Cardiology, 2013, 163, 3, 266

    CrossRef

  15. 15
    Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Francesco Salvo, Federica Nicotra, Miriam Sturkenboom, Susana Perez-Gutthann, Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies, Pharmacoepidemiology and Drug Safety, 2013, 22, 6
  16. You have free access to this content16
    Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg, Jerry H. Gurwitz, A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data, Pharmacoepidemiology and Drug Safety, 2012, 21,
  17. 17
    Prarthana Thiagarajan, Janusz A. Jankowski, Aspirin and NSAIDs; benefits and harms for the gut, Best Practice & Research Clinical Gastroenterology, 2012, 26, 2, 197

    CrossRef

  18. 18
    Yi-Ju Chen, Yun-Ting Chang, Jui-Lung Shen, Tzu-Ting Chen, Chang-Bi Wang, Chuan-Mu Chen, Chun-Ying Wu, Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: A nationwide cohort study, Arthritis & Rheumatism, 2012, 64, 6
  19. 19
    Eric J Lavonas, James F Fries, Daniel E Furst, Kenneth J Rothman, Andy Stergachis, Allen J Vaida, Daniel Zelterman, Kate M Reynolds, Jody L Green, Richard C Dart, Comparative risks of non-prescription analgesics: a structured topic review and research priorities, Expert Opinion on Drug Safety, 2012, 11, 1, 33

    CrossRef

  20. 20
    Asad Umar, Barbara K. Dunn, Peter Greenwald, Future directions in cancer prevention, Nature Reviews Cancer, 2012, 12, 12, 835

    CrossRef

  21. 21
    Phyllis Dan, Gennady Rosenblat, Saul Yedgar, Phospholipase A2 activities in skin physiology and pathology, European Journal of Pharmacology, 2012, 691, 1-3, 1

    CrossRef

  22. 22
    Wen-Yi Shau, Hsi-Chieh Chen, Shu-Ting Chen, Hsu-Wen Chou, Chia-Hsuin Chang, Chuei-Wen Kuo, Mei-Shu Lai, Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence, BMC Cardiovascular Disorders, 2012, 12, 1, 4

    CrossRef

  23. 23
    Christopher W. McIntyre, Susan Shaw, Mohamed T. Eldehni, Brenner and Rector's The Kidney, 2012,

    CrossRef

  24. 24
    Stephen J. Kerr, Debra S. Rowett, Geoffrey P. Sayer, Susan D. Whicker, Deborah C. Saltman, Andrea Mant, All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study, British Journal of Clinical Pharmacology, 2011, 71, 6
  25. 25
    Seong Jun Park, Helmut Buschmann, Carsten Bolm, Bioactive sulfoximines: Syntheses and properties of Vioxx® analogs, Bioorganic & Medicinal Chemistry Letters, 2011, 21, 16, 4888

    CrossRef

  26. 26
    H. Pieringer, M. Pichler, Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications, QJM, 2011, 104, 1, 13

    CrossRef

  27. 27
    Yun-xiang Cao, Jian Liu, Yan Zhu, Effect of Xinfeng Capsule (新风胶囊) on the cardiac function in patients with rheumatoid arthritis, Chinese Journal of Integrative Medicine, 2011, 17, 10, 738

    CrossRef

  28. 28
    Ying-Hsin Chen, Chao-Yuan Chang, Yun-Hsin Wang, Chi-Chung Wen, Yun-Chen Chen, Sheng-Chuan Hu, Dah-Shyong Yu, Yau-Hung Chen, Embryonic exposure to diclofenac disturbs actin organization and leads to myofibril misalignment, Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2011, 92, 2
  29. 29
    Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Antoine Pariente, Lorenza Scotti, Miriam Sturkenboom, Susana Perez-Gutthann, Stroke risk and NSAIDs: a systematic review of observational studies, Pharmacoepidemiology and Drug Safety, 2011, 20, 12
  30. 30
    Amanda R. Patrick, William H. Shrank, Robert J. Glynn, Daniel H. Solomon, Colin R. Dormuth, Jerry Avorn, Suzanne M. Cadarette, Helen Mogun, M. Alan Brookhart, The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults, Value in Health, 2011, 14, 4, 513

    CrossRef

  31. 31
    Robyn E. Fary, Graeme J. Carroll, Tom G. Briffa, N. K. Briffa, The effectiveness of pulsed electrical stimulation in the management of osteoarthritis of the knee: Results of a double-blind, randomized, placebo-controlled, repeated-measures trial, Arthritis & Rheumatism, 2011, 63, 5
  32. 32
    Vincent E. Friedewald, Joel S. Bennett, J. Paul Christo, James L. Pool, James M. Scheiman, Lee S. Simon, Vibeke Strand, William B. White, Gary W. Williams, William C. Roberts, AJC Editor's Consensus: Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk, The American Journal of Cardiology, 2010, 106, 6, 873

    CrossRef

  33. 33
    Aneta Perić, Marija Toskić-Radojičić, Silva Dobrić, Nemanja Damjanov, Branislava Miljković, Mirjana Antunović, Sandra Vezmar, Are COX-2 inhibitors preferable to combined NSAID and PPI in countries with moderate health service expenditures?, Journal of Evaluation in Clinical Practice, 2010, 16, 6
  34. 34
    Michael J. Marmura, Mary Hopkins, Jocelyn Andrel, William B. Young, David M. Biondi, Marcia F.T. Rupnow, Robert B. Armstrong, Electronic Medical Records as a Research Tool: Evaluating Topiramate Use at a Headache Center, Headache: The Journal of Head and Face Pain, 2010, 50, 5
  35. You have free access to this content35
    Arduino A. Mangoni, Richard J. Woodman, Paraskevi Gaganis, Andrew L. Gilbert, Kathleen M. Knights, Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community, British Journal of Clinical Pharmacology, 2010, 69, 6
  36. 36
    Arduino A. Mangoni, Richard J. Woodman, Andrew L. Gilbert, Kathleen M. Knights, Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community, Pharmacoepidemiology and Drug Safety, 2010, 19, 5
  37. 37
    Peter M. Wahl, Keith Rodgers, Sebastian Schneeweiss, Brian F. Gage, Javed Butler, Charles Wilmer, Marshall Nash, Gregory Esper, Norman Gitlin, Neal Osborn, Louise J. Short, Rhonda L. Bohn, Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population, Pharmacoepidemiology and Drug Safety, 2010, 19, 6
  38. 38
    U. Bergstrom, L. T. H. Jacobsson, C. Turesson, Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden, Rheumatology, 2009, 48, 12, 1600

    CrossRef

  39. 39
    Geoffrey A Pietersz, Patricia L Mottram, Nicholas C van de Velde, Caroline Tan Sardjono, Sandra Esparon, Paul A Ramsland, Gerard Moloney, Jonathan B Baell, Tom D McCarthy, Barry R Matthews, Maree S Powell, P Mark Hogarth, Inhibition of destructive autoimmune arthritis in FcγRIIa transgenic mice by small chemical entities, Immunology and Cell Biology, 2009, 87, 1, 3

    CrossRef

  40. 40
    Christianne L. Roumie, Neesha N. Choma, Lisa Kaltenbach, Edward F. Mitchel, Jr, Patrick G. Arbogast, Marie R. Griffin, Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events–stroke, acute myocardial infarction, and death from coronary heart disease, Pharmacoepidemiology and Drug Safety, 2009, 18, 11
  41. 41
    Choon Bok Joeng, Javed H. Niazi, Su Jin Lee, Man Bock Gu, ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid, Bioorganic & Medicinal Chemistry, 2009, 17, 15, 5380

    CrossRef

  42. 42
    Panagiotis G. Tsailas, George C. Babis, Konstantinos Nikolopoulos, Panayotis N. Soucacos, Dimitrios S. Korres, The Effectiveness of Two COX-2 Inhibitors in the Prophylaxis Against Heterotopic New Bone Formation: An Experimental Study in Rabbits, Journal of Surgical Research, 2009, 151, 1, 108

    CrossRef

  43. 43
    E. Chilet-Rosell, M. T. Ruiz-Cantero, J. F. Horga, Women's health and gender-based clinical trials on etoricoxib: methodological gender bias, Journal of Public Health, 2009, 31, 3, 434

    CrossRef

  44. 44
    J.K. Aronson, 2009,

    CrossRef

  45. 45
    Lee S. Simon, Current Therapy in Pain, 2009,

    CrossRef

  46. 46
    Zurab Nadareishvili, Kaleb Michaud, John M. Hallenbeck, Frederick Wolfe, Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case–control study, Arthritis Care & Research, 2008, 59, 8
  47. 47
    R. Tsutsumi, H. Ito, T. Hiramitsu, K. Nishitani, M. Akiyoshi, T. Kitaori, T. Yasuda, T. Nakamura, Celecoxib inhibits production of MMP and NO via down-regulation of NF-κB and JNK in a PGE2 independent manner in human articular chondrocytes, Rheumatology International, 2008, 28, 8, 727

    CrossRef

  48. 48
    Hyun Soo Kim, Joydeb Kumar Kundu, Jeong-Sang Lee, Tae-Young Oh, Hye-Kyung Na, Young-Joon Surh, Chemopreventive Effects of the Standardized Extract (DA-9601) ofArtemisia asiaticaon Azoxymethane-Initiated and Dextran Sulfate Sodium-Promoted Mouse Colon Carcinogenesis, Nutrition and Cancer, 2008, 60, sup1, 90

    CrossRef

  49. 49
    V. Rajakrishnan, V. R. Manoj, Gita Subba Rao, Computer-Aided, Rational Design of a Potent and Selective Small Peptide Inhibitor of Cyclooxygenase 2 (COX2), Journal of Biomolecular Structure and Dynamics, 2008, 25, 5, 535

    CrossRef

  50. 50
    T. R. Cowley, B. Fahey, S. M. O’Mara, COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo, European Journal of Neuroscience, 2008, 27, 11
  51. 51
    Anthony Sebba, Efficacy and safety of etoricoxib in the treatment of osteoarthritis, Expert Review of Clinical Pharmacology, 2008, 1, 3, 345

    CrossRef

  52. 52
    Roger Jones, Greg Rubin, Francis Berenbaum, James Scheiman, Gastrointestinal and Cardiovascular Risks of Nonsteroidal Anti-inflammatory Drugs, The American Journal of Medicine, 2008, 121, 6, 464

    CrossRef

  53. 53
    Wolfgang C. Winkelmayer, Sushrut S. Waikar, Helen Mogun, Daniel H. Solomon, Nonselective and Cyclooxygenase-2-Selective NSAIDs and Acute Kidney Injury, The American Journal of Medicine, 2008, 121, 12, 1092

    CrossRef

  54. 54
    Shigeru Ushiyama, Tomoko Yamada, Yukiko Murakami, Sei-ichiro Kumakura, Shin-ichi Inoue, Keisuke Suzuki, Akira Nakao, Akihiro Kawara, Tomio Kimura, Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects, European Journal of Pharmacology, 2008, 578, 1, 76

    CrossRef

  55. 55
    Daniel H. Solomon, Robert J. Glynn, Kenneth J. Rothman, Sebastian Schneeweiss, Soko Setoguchi, Helen Mogun, Jerry Avorn, Til Stürmer, Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups, Arthritis Care & Research, 2008, 59, 8
  56. 56
    Carla R. Scanzello, Neal K. Moskowitz, Allan Gibofsky, The Post-NSAID Era: What to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis, Current Rheumatology Reports, 2008, 10, 1, 49

    CrossRef

  57. 57
    Vibeke Strand, Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?, The Lancet, 2007, 370, 9605, 2138

    CrossRef

  58. 58
    S.M. Berney, Cardiovascular Outcomes in New Users of Coxibs and Nonsteroidal Antiinflammatory Drugs: High-Risk Subgroups and Time Course of Risk, Yearbook of Medicine, 2007, 2007, 45

    CrossRef

  59. 59
    Carl Turesson, Eric L Matteson, Cardiovascular risk factors, fitness and physical activity in rheumatic diseases, Current Opinion in Rheumatology, 2007, 19, 2, 190

    CrossRef

  60. 60
    Andreas Wagenitz, Edgar A. Mueller, Adrian Frentzel, Nathalie Cambon, Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population*, Current Medical Research and Opinion, 2007, 23, 8, 1957

    CrossRef

  61. 61
    Ignatius Gerardo E. Zarraga, Ernst R. Schwarz, Coxibs and Heart Disease, Journal of the American College of Cardiology, 2007, 49, 1, 1

    CrossRef

  62. 62
    N. S. ABRAHAM, H. B. EL-SERAG, C. HARTMAN, P. RICHARDSON, A. DESWAL, Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident, Alimentary Pharmacology & Therapeutics, 2007, 25, 8
  63. 63
    Ville-Veikko Hynninen, Klaus T. Olkkola, Kari Leino, Stefan Lundgren, Pertti J. Neuvonen, Anders Rane, Mika Valtonen, Kari Laine, Effect of voriconazole on the pharmacokinetics of diclofenac, Fundamental & Clinical Pharmacology, 2007, 21, 6
  64. 64
    Deana Lazaro, Elderly-Onset Systemic Lupus Erythematosus, Drugs & Aging, 2007, 24, 9, 701

    CrossRef

  65. 65
    Li Zhang, Anne M. Bertucci, Kimberly A. Smith, Luting Xu, Syamal K. Datta, Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus, Arthritis & Rheumatism, 2007, 56, 12
  66. 66
    Kay Brune, Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability, Current Medical Research and Opinion, 2007, 23, 12, 2985

    CrossRef

  67. 67
    Hidetaka Tsumura, Isamu Tamura, Hiroshi Tanaka, Ryo Chinzei, Tsukasa Ishida, Atsuhiro Masuda, Hideyuki Shiomi, Yoshinori Morita, Masaru Yoshida, Hiromu Kutsumi, Hideto Inokuchi, Minoru Doita, Masahiro Kurosaka, Takeshi Azuma, Prescription of Nonsteroidal Anti-inflammatory Drugs and Co-prescribed Drugs for Mucosal Protection: Analysis of the Present Status Based on Questionnaires Obtained from Orthopedists in Japan, Internal Medicine, 2007, 46, 13, 927

    CrossRef

  68. 68
    Carla R. Scanzello, Neal K. Moskowitz, Allan Gibofsky, The post-NSAID era: What to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis, Current Pain and Headache Reports, 2007, 11, 6, 415

    CrossRef

  69. 69
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2006, 15, 11
  70. 70
    Kyung-Soo Chun, Joydeb Kumar Kundu, Kwang-Kyun Park, Won-Yoon Chung, Young-Joon Surh, Inhibition of Phorbol Ester-induced Mouse Skin Tumor Promotion and COX-2 Expression by Celecoxib: C/EBP as a Potential Molecular Target, Cancer Research and Treatment, 2006, 38, 3, 152

    CrossRef

  71. 71
    Kyung-Soo Chun, Joydeb Kumar Kundu, Kwang-Kyun Park, Won-Yoon Chung, Young-Joon Surh, Inhibition of Phorbol Ester-induced Mouse Skin Tumor Promotion and COX-2 Expression by Celecoxib: C/EBP as a Potential Molecular Target, Cancer Research and Treatment, 2006, 38, 3, 152

    CrossRef

  72. 72
    Nick Barker, Hans Clevers, Mining the Wnt pathway for cancer therapeutics, Nature Reviews Drug Discovery, 2006, 5, 12, 997

    CrossRef

  73. 73
    Antonio González-Pérez, Luis Alberto García Rodriguez, Cardiovascular Toxicities of NSAIDS: Epidemiologic Aspects,
  74. 74
    References,